Remarkably, MDR1 promoter methylation is very frequent in prostate carcinoma (PCa) [11-13], which represents the second most frequent neoplasia among male population worldwide (13.6% of the total) and the fifth most common cancer overall [14], being the second leading cause of cancer-related death in men [15]. This evidence concerns the gene ABCB1 and prostate carcinoma.